Lv11
30 积分 2024-08-28 加入
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
2小时前
已完结
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
12天前
已完结
Cancer therapy with antibodies
1个月前
已完结
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
3个月前
已完结
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
3个月前
已完结
皖公网安备34019202002308
